Y Intercept (Hong Kong) LTD Zai Lab LTD Transaction History

Y Intercept (Hong Kong) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $243,292 - $564,208	-8,761 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $295,142 - $565,608	5,376 Added 158.82%	8,761 $551,000
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $355,425 - $603,782	3,385 New	3,385 $357,000
Q2 2021 Aug 12, 2021	SELL	$125.11 - $180.0 $921,935 - $1.33 Million	-7,369 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$126.27 - $191.71 $930,483 - $1.41 Million	7,369 New	7,369 $954,000

117

40.9M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.21B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.